16:08 EDT Stoke Therapeutics (STOK) files automatic mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STOK:
- Stoke Therapeutics price target raised to $38 from $36 at Wedbush
- STOK Earnings this Week: How Will it Perform?
- Stoke Therapeutics, Biogen publish data from zorevunersen studies in NEJM
- Nanogen appoints Ruff as Chief Regulatory Affairs Officer, McSherry as SVP
- Stoke Therapeutics Awards Discretionary Bonus to CEO Smith